ValueCorp & Partnered Clients

Below find a partial list of companies using effective IR & PR.

Access Pharmaceuticals Inc. (OTC QB: ACCP)

Access Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes proprietary products for the treatment and supportive care of cancer patients. The company’s products include MuGard, which has received FDA marketing clearance for the management of patients with mucositis; ProLindac, a DACH Platinum in Phase II clinical testing of patients with ovarian cancer; and Thiarabine(TM), a nucleoside analog in a Phase I/IIa trial in hematological malignancies. It also has other advanced drug delivery technologies, such as CobaCyte-mediated targeted delivery and CobOral-oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism. The company has a collaborative development agreement with bioRASI, LLC to facilitate clinical development for the company’s CobOral based oral insulin and CobaCyte based products. Access Pharmaceuticals, Inc. was founded in 1988 and is based in Dallas, Texas.

 

Apricus Biosciences Inc. (Nasdaq CM: APRI )

Apricus Biosciences, Inc. engages in the design and development of pharmaceutical products and product candidates based on its patented NexACT drug delivery technology. The NexACT drug delivery technology is designed to enhance the delivery of an active drug to improve therapeutic outcomes and reduce systemic side effects that accompany existing oral and injectable medications. The company is also seeking commercialization partnerships for its product, Vitaros, which is approved in Canada for the treatment of erectile dysfunction (ED); and its additional existing clinical and pre-clinical pipeline of product candidates, such as Femprox for female sexual arousal disorder, MycoVa for onychomycosis excluding tinea pedis (nail fungal infection), RayVa for Raynaud’s Syndrome, and PrevOnco for liver cancer. It has compounds in development from pre-clinical through Phase III in the areas of sexual dysfunction, oncology, dermatology, autoimmune, pain, anti-infectives, diabetes, and cosmeceuticals. The company was founded in 1987 and is headquartered in San Diego, California.

 

Atossa Genetics Inc. (Nasdaq CM: ATOS )

Atossa Genetics Inc. is focused on improving breast health through the development of laboratory developed tests (LDTs), medical devices and therapeutics. The Company's LDTs are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. The LDT's and the Company's medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For additional information, please visit www.atossagenetics. com.

 

Chanticleer Holdings Inc. (NASDAQ CM: HOTR)

Chanticleer Holdings, Inc. owns and operates Hooters branded restaurants in emerging international markets. Hooters is one of the most well-known restaurant brands in the world and has a menu which consists of moderately-priced American bar food and the world-famous Hooters girls.  The Company owns all or part of the Hooters franchise rights to develop and operate Hooters restaurants in South Africa, Eastern Europe, five states of Brazil, parts of United Kingdom, Oregon and Washington in the U.S., and has joint ventured with the existing franchisee in Australia, while evaluating several additional opportunities internationally.

Chanticleer also owns and operates American Roadside Burgers, a Charlotte, NC based chain, and owns a majority interest in Just Fresh Restaurants, a fresh food-focused casual dining establishment based in Charlotte, NC. The Company also owns Chef Tesar inspired Spoon Bar & Kitchen in Dallas, TX. The Company continues to evaluate opportunities to grow both organically and through franchising opportunities for its brands.

 

Clean Coal Tecnologies Inc. (OTC QB: CCTC)

Clean Coal Technologies, Inc., a cleaner-energy technology company with headquarters in New York City, NY, holds patented process technology and other intellectual property that converts raw coal into a cleaner burning fuel. The Company's trademarked end products, "Pristine™" coals, are significantly more efficient, less polluting, more cost-effective, and provide more heat than untreated coal. The principal elements of the Company's pre combustion technology are based on well-proven science and tried-and-tested industrial components. The Company's clean coal technology may reduce some 90% of chemical pollutants from coal, including Sulfur and Mercury, thereby reducing emissions affecting some coal-fired power plants.

 

Inuvo Inc. (AMEX: INUV )

Inuvo, Inc. provides software and analytics technology solutions over the Internet for use by online advertisers and Website publishers. The company operates in two segments, Exchange and Direct. The Exchange segment designs, builds, implements, manages, and sells various technology and analytics platforms that support online marketing. Its solutions include ValidClick service at validclick.com, which is a fraud filtering pay-per-click marketplace where publishers integrate advertisements within their Websites based on the demographics and natural search behaviors of the consumer; MyAP affiliate platform at myap.com, an affiliate tracking and management software solution that provide advertisers the ability to sign up, manage, and track the activities of their publishers; and Inuvo open platform where advertisers and publishers interact. This segment solutions also comprise LocalXML service at localxml.com, which allows publishers to make real-time calls to the LocalXML database; Yellowise.com directory search Website, a local search and review Website powered by the LocalXML service; Zubican.com business-to-business directory search Website, a business directory powered by LocalXML that connects business-to-business buyers and sellers; and BargainMatch.com service, which allows publishers to offer their visitors an online shopping experience. The Direct segment designs, builds, implements, and operates various Websites for the sale of products, services, data, and advertising. This segment manages owned and operated Web properties across verticals that include professional recertification and baby products. This segment uses a number of online tactics for lead generation, including search and affiliate, and email marketing campaigns designed to drive traffic to the Website. The company was formerly known as Kowabunga! Inc. and changed its name to Inuvo, Inc. in July 2009. Inuvo, Inc. is headquartered in Clearwater, Florida.

 

InVivo Therapeutics Corp. (OTC BB: NVIV.OB )

InVivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. It focuses on developing biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel for local controlled release of methylprednisolone to treat acute spinal cord injuries; and biocompatible polymer scaffolding devices seeded with autologous human neural stem cells to treat acute and chronic spinal cord injuries. The company was founded in 2005 and is based in Cambridge, Massachusetts.

 

Lilis Energy Inc. (NASDAQ CM: LLEX)

Lilis Energy, Inc. is a Denver-based independent oil and gas exploration and production company focused on the Denver-Julesburg (DJ) Basin where it holds approximately 123,000 gross, 107,000 net acres. Management has more than 80 years of experience, with petroleum geology expertise throughout the Rockies.

Lilis Energy’s near term focus is to identify and develop a balanced portfolio of low risk, high return drilling prospects that include both unconventional sites that target various oil shale horizons and low risk, conventional offsets to existing production. The Company’s asset base is comprised of current production and reserves from the Cretaceous “J” Sandstone along with extensive prospectivity for other oil-bearing formations including the conventional Wykert Sandstone. Multiple unconventional opportunities include the Niobrara Oil Shale; Codell Sandstone; Greenhorn Limestone; Permian, and Pennsylvania horizons.

 

MamaMancini's Holdings Corp. (OTC QB: MMMB)

MamaMancini's is a manufacturer and distributor of a line of all natural, beef meatballs with sauce, turkey meatballs with sauce, chicken meatballs with sauce, pork meatballs with sauce, and other similar Italian products. The Company's sales have been growing on a consistent basis as the Company expands its distribution channel, which includes major retailers such as Costco, Publix, Shop Rite, Price Chopper, A&P, Waldbaums, Food Emporium, Whole Foods, Shaw's Supermarkets, Kings, Key Foods, Giant Eagle, Stop-n-Shop, Giant Stores, Food Town, Kroger, Winn Dixie, Albertsons, Shoppers, Wal-Mart, Marsh's Supermarkets, Bashas, Bi-Lo, Central Markets, Weis Markets, Ingles, and The Fresh Market. For more information please visit the company’s website at www.mamamancinis.com.

 

New Western Energy Corp. (OTC QB: NWTR)

New Western Energy Corp. is an independent energy company engaged in the acquisition, development, production, and exploration of oil, gas and minerals primarily in North America. To learn more about the Company, visit: www.newwesternenergy.com.

 

Pharma-Bio Serv Inc. (OTC QB: PBSV)

Pharma-Bio Serv is a compliance, project management and technology transfer support consulting firm, headquartered in Puerto Rico, with operations in the U.S., Ireland and Spain. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance related services with integrated portfolio services including microbiological and chemical testing services for clients in the Pharmaceutical, Biotechnology, Chemical, Medical Device, Cosmetic, Food and Allied Products industries, at its laboratory testing facility in Puerto Rico. Services also include "Integratek," an information technology consulting practice, and "Pharma Serv Academy" a division that provides technical and regulatory standards seminars/training conducted by industry experts. The Company's global team includes more than 300 leading engineering and life science professionals, quality assurance managers and directors.

 

Pressure BioSciences, Inc. (OTC QB: PBIO )

Pressure BioSciences, Inc., a life sciences company, engages in the development and commercialization of pressure cycling technology (PCT) in the United States. The company’s PCT technology uses instrumentation that cycles pressure between ambient and ultra-high levels at controlled temperatures to control the interactions of bio-molecules. It offers Barocycler instrumentation products, including Barocycler NEP3229 that processes up to three samples using its single-use PULSE Tubes; Barocycler NEP2320, which processes one sample at a time and works on compressed air; PCT MicroTube Adapter Kit to process up to 48 samples simultaneously; The PCT Shredder, which is designed to disrupt tough samples, such as ticks, muscle, and seeds; and The Shredder SG3, a shear mechanical homogenization system. The company’s consumable product line comprises The FT500 PULSE Tube that transmits the power of PCT from Barocycler instrument to sample; ProteoSolve for Lipid Rich Samples, a PCT-dependent method for the extraction of proteins from lipid-rich samples, including adipose and brain tissues, organelles, and membrane preparations; ProteoSolve for Systems Biology, a PCT-dependent method for the extraction, isolation, and fractionation of nucleic acids, proteins, and lipids; ProteoSolve for Conventional Extraction, a PCT-dependent kit for the extraction of proteins; and Mitochondria Isolation Kits to extract mitochondria from skeletal muscle and lung tissue for subsequent analysis. Its PCT also has applications in various life sciences areas, such as genomic, proteomic, and small molecule sample preparation. Pressure BioSciences serves academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life science companies. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in February 2005. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.

 

Sebring Software Inc. (OTC QB: SMXI)

Sebring is in the software business and is focused on the Dental Practice Management industry ("DPM"). DPM companies combine acquisition and organic growth to boost revenues while instilling best practice management infrastructure to increase the dental practices' profitability. Capital and cost efficiency have driven the dental services industry to join DPM companies rather than remain as sole practitioners. Most DPMs and dental practices use different software packages. Sebring plans to use software solutions to substantially reduce the cost of DPMs data entry.  For more information about Sebring Management, please visit www.sebringusa.com.

 

Sysorex Global Holdings Inc. (NASDAQ CM: SYRX)

Through focused, custom technology solutions, Sysorex provides cyber security, data analytics, custom application development, cloud solutions, Mobile/BYOD solutions and strategic outsourcing to government and commercial clients in major industries around the world. From identifying security risks to helping clients realize value from their big data strategies, Sysorex has the experience, technology, partners, and agility to be your trusted IT partner. Visit www.sysorex.com, follow @SysorexGlobal and Like us on Facebook.

 

Tonix Pharmaceuticals Inc. (NASDAQ CM: TNXP)

TONIX Pharmaceuticals is developing new therapies for challenging disorders of the central nervous system. The Company targets conditions characterized by significant unmet medical need, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. TONIX reformulates known pharmaceutical agents to design drugs with optimal safety, efficacy and predictability. Its most advanced product candidate, TNX-102 SL, is in development for fibromyalgia and PTSD.

 

TransCoastal Energy Inc. (OTC QB: TCEC)

TransCoastal Corporation is an independent oil & gas company formed in August 1998 and headquartered in Dallas, Texas. Since inception, TransCoastal's growth has focused on the acquisition of producing oil and gas properties. The Company's strategy is driven by exploitation opportunities of proven yet underdeveloped mature oil and gas fields, which possess long-life reserve potential with low risk development opportunities. For further information on the Company, please visit TransCoastal's website at www.TransCoastal.net.

 

Please enter your information below to receive more information from CorProminence.